or Try an Advanced Search...

    Blastoma Stocks List

    Symbol Grade Name % Change
    PRLD F Prelude Therapeutics Incorporated 0.57
    AFMD F Affimed Therapeutics B.V. -2.94
    PSTV F Plus Therapeutics, Inc. 0.84
    TCON F TRACON Pharmaceuticals, Inc. -31.40
    CLRB F Cellectar Biosciences, Inc. 1.28
    CRVO F CervoMed Inc. -0.62
    RGLS F Regulus Therapeutics Inc. 0.00
    YMAB F Y-mAbs Therapeutics, Inc. -4.17
    CLLS F Cellectis S.A. -2.62
    CLDX F Celldex Therapeutics, Inc. -0.68
    View As Page of Charts
    Related Industries: Biotechnology Medical Instruments & Supplies
    Related Stock Lists: Cancer Glioblastoma Medicine Oncology Brain Tumor Biopharmaceutical Chemotherapy Solid Tumors Biotechnology Cancer Treatment Clinical Development Clinical Medicine Ovarian Cancer Acute Myeloid Leukemia Antineoplastic Drugs CD19 Cancer Cell Chronic Lymphocytic Leukemia Hematologic Malignancies Lymphocytic Leukemia

    Related ETFs - A few ETFs which own one or more of the above listed Blastoma stocks.

    Symbol Grade Name Weight
    PBE D PowerShares Dynamic Biotech & Genome 5.74
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 3.9
    PJP D PowerShares Dynamic Pharmaceuticals 3.7
    FBT D First Trust Amex Biotech Index Fund 3.64
    GLRY A Inspire Faithward Mid Cap Momentum ESG ETF 3.33
    View all Blastoma ETFs...
    Compare ETFs
    Compare FTXH to PJP Compare PBE to GLRY Compare PJP to GLRY

        Blastoma Stocks Recent News

        Date Stock Title
        Nov 20 CLDX Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
        Nov 20 CLDX Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
        Nov 19 AFMD Is Affimed N.V. (AFMD) the Best German Stock to Buy Now?
        Nov 19 CLRB Q3 2024 Cellectar Biosciences Inc Earnings Call
        Nov 18 CLRB Cellectar Biosciences, Inc. (CLRB) Q3 2024 Earnings Call Transcript
        Nov 18 CLRB Cellectar Biosciences GAAP EPS of -$0.40 misses by $0.03
        Nov 18 CLRB Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update
        Nov 18 CLRB Earnings Scheduled For November 18, 2024
        Nov 17 PSTV Plus Therapeutics Third Quarter 2024 Earnings: Beats Expectations
        Nov 16 PSTV Plus Therapeutics, Inc. (PSTV) Q3 2024 Earnings Call Transcript
        Nov 15 CLRB Cellectar Biosciences Q3 2024 Earnings Preview
        Related Industries: Biotechnology Medical Instruments & Supplies
        Related Stock Lists: Cancer Glioblastoma Oncology Biotechnology Brain Tumor Medicine Neuroblastoma Brain Cancer Chemotherapy Ovarian Cancer Stage Pharmaceutical Transcription Transcription Factor Transcription Factors ATM Acute Myeloid Leukemia Aging Associated Diseases Alcohol Antineoplastic Drugs Biopharmaceutical
        Blastoma

        A blastoma is a type of cancer, more common in children, that is caused by malignancies in precursor cells, often called blasts. Examples are nephroblastoma, medulloblastoma, and retinoblastoma. The suffix -blastoma is used to imply a tumor of primitive, incompletely differentiated (or precursor) cells, e.g., chondroblastoma is composed of cells resembling the precursor of chondrocytes.

        More about Blastoma
        Browse All Tags